Enrolling now
Lebrikizumab Trial for Atopic Dermatitis
Nationwide
2 sites in CA, MI
← All conditions
Atopic Dermatitis
40 recruiting trials
A chronic, inflammatory skin condition causing intense itching, redness, and dry skin, often starting in childhood.
50 states35% with remote optionsRefreshed dailyFree to join
What trials involve
✓
Biologic drugs
Examples: Dupilumab
✓
Topical treatments
Examples: JAK inhibitors
✓
Oral medications
Examples: Corticosteroids
What to expect
Screening
A short eligibility check — usually 5–10 minutes online or by phone. No commitment required.
Your visit schedule
Varies by trial. Many offer remote check-ins. Travel and time costs are often reimbursed.
Your rights
You can withdraw from a trial at any time, for any reason, with no impact on your regular care.
Who to contact
Use the official ClinicalTrials.gov listing to decide what to ask your clinician or the study team.
Recent opportunities
Trials enrolling now
Enrolling now
A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Single and Multiple Dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis
Nationwide
3 sites in AR, PA
Enrolling now
A Study of BBT001
Nationwide
1 site in NY
Enrolling now
FIH Study to Evaluate the Tolerability of PF-07832837
Nationwide
3 sites in CA, FL, PA
Enrolling now
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
Nationwide
81 sites in AL, AR, AZ +24
Enrolling now
Dupilumab De-escalation in Pediatric Atopic Dermatitis
Nationwide
1 site in MD
Ready to see if you qualify?
Most patients find their first match in under two minutes.